Physician profile
Michael A Mcdonald
NPI 1679563530
$1,316.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $255 · 2021: $72.31 · 2022: $42.64.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $206.62 | 2019-2020 | |
| Glaxosmithkline, LLC. | $179.61 | 2019-2020 | |
| Novo Nordisk INC | $149.69 | 2019-2022 | |
| Lilly USA, LLC | $128.89 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.82 | 2019-2021 | |
| Amgen INC. | $105.04 | 2019 | |
| Merck Sharp & Dohme LLC | $89.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $56.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.03 | 2019-2020 | |
| Abbvie INC. | $39.52 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $37.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.09 | 2019 | |
| Allergan, INC. | $34.96 | 2019-2020 | |
| Amarin Pharma, INC. | $34.66 | 2019-2020 | |
| Alkermes, INC. | $24.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $16.30 | 2019 | |
| Boston Scientific Corporation | $14.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.